• US: +1 9176726599
  • Login

Interatrial Shunt Device Market Size By Indication (Heart failure with reduced ejection fraction (HFrEF), Heart failure with reduced ejection fraction (HFrEF)), End-user (Clinics, Hospitals, Cardiac Centers, Others) Regional Forecast to 2021–2027

Format: PDF | Pages: 288 | Report ID: MRS1087


Report Description

The global Interatrial Shunt Device market size is estimated at USD 180.4 Thousand in 2020, expanding at a CAGR 3.2% from 2021-2027 to reach 270.1 Thousand USD in 2027.

Market Dynamics

The interatrial shunt is designed for minimally invasive administration towards the heart via catheter-based devices. The dime-sized device is inserted in the septal barrier between atrial lobes and allows blood to flow from the side to side ventricle. The machine is deployed following transseptal perforation of the semi-oval, placement of the shipping cannula into the chest cavity and deployment of the mitral valve disc, verification of the shipping catheter's right heart place, and deployment of the right heart disc so that the machine is secured from across atrial septum as well as sits cleanse on the mitral valve side. Increased pharmaceutical research throughout the world has resulted in pharmacologic breakthroughs that aid in the treatment of patients having heart disease because there has been a reduction in discharges with sacubitril/valsartan. Furthermore, the rising usage and need for different therapeutic approaches have aided the expansion of the worldwide interatrial shunt device industry. The interatrial shunt gadget manufactured by V-Wave technology by V-Wave Ltd with Corvia Medical Inc. is a current revolutionary interventional device therapy that has shown in preliminary and early testing. Alongside such improvements, the industry's growth potential tends to expand and introduce additional growth chances.

Regional Insights

Geographically, America is the largest producer to the interatrial shunt device industry and is expected to maintain its position during the anticipated time period due to the existence of a large elderly demographic and a large patient group with cardiac diseases. In the forecast time range, Europe is expected to be the second-largest interatrial shunt device industry. The growth of the interatrial shunt device industry in the area may be attributed to an increase in the number of cases of heart failure and other heart-related problems, as well as a growth in the frequency of cardiac surgeries in Europe. Nevertheless, the Asia-Pacific industry is expected to grow at a high pace over the forecast time window. This is mostly due to a growth in the quantity of cardiac medical centers, as well as advancements in the healthcare system, technology advancements, and growing public knowledge of the treatment options available in the industry.

Segment Insights

The Interatrial Shunt Device market is fragmented into the indication, and End-user, Based on the end-user, the global interatrial shunt device market is segmented on the basis of clinics, hospitals, cardiac centers, and others. Based on indication type the global Interatrial Shunt Device market indication segment is further segmented on the basis of Heart failure with reduced ejection fraction (HFrEF) and Heart failure with preserved ejection fraction (HFpEF).

Key Players Insights

The worldwide market is relatively fragmented, with a significant number of foreign and domestic companies present. Key companies are expected to focus on growth initiatives in order to increase the area position of the market, raise brand recognition, and enter emerging regions. These companies' primary goal is on improving their offerings in order to increase revenue and attract a larger client base. Some other key technique used by market actors to improve their market position is strategic partnerships.

The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses market size and forecast of Interatrial Shunt Devices by Indication, region, and End-user. In addition, this report introduces the market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products, etc.):

  • V-Wave Ltd.
  • SHANGHAI SHAPE MEMORY ALLOY CO., LTD.
  • Tewksbury
  • KMUTT
  • Corvia Medical
  • Others

 Indication Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Heart failure with reduced ejection fraction (HFrEF)
  • Heart failure with reduced ejection fraction (HFrEF)

End-user Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Clinics
  • Hospitals
  • Cardiac Centers
  • Others

Region Coverage (Regional Consumption, Demand & Forecast by Countries, etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina, etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa, etc.)

Frequently Asked Questions

The market for interatrial shunt devices is anticipated to reach USD 180.4 Thousand in 2020 and CAGR 3.2% from 2021 to 2027.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
With a CAGR of 3.2% from 2021 to 2027, it is expected that interatrial shunt devices will reach USD 180.4 Thousand in 2020.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
The worldwide market is relatively fragmented, with a significant number of foreign and domestic companies present. Key companies are expected to focus on growth initiatives in order to increase the area position of the market, raise brand recognition, and enter emerging regions. These companies' primary goal is on improving their offerings in order to increase revenue and attract a larger client base. Some other key technique used by market actors to improve their market position is strategic partnerships.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.